» Articles » PMID: 34591597

Diagnostic Performance of Qualitative and Radiomics Approach to Parotid Gland Tumors: Which is the Added Benefit of Texture Analysis?

Abstract

Objective: To investigate whether MRI-based texture analysis improves diagnostic performance for the diagnosis of parotid gland tumors compared to conventional radiological approach.

Methods: Patients with parotid gland tumors who underwent salivary glands MRI between 2008 and 2019 were retrospectively selected. MRI analysis included a qualitative assessment by two radiologists (one of which subspecialized on head and neck imaging), and texture analysis on various sequences. Diagnostic performances including sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC) of qualitative features, radiologists' diagnosis, and radiomic models were evaluated.

Results: Final study cohort included 57 patients with 74 tumors (27 pleomorphic adenomas, 40 Warthin tumors, 8 malignant tumors). Sensitivity, specificity, and AUROC for the diagnosis of malignancy were 75%, 97% and 0.860 for non-subspecialized radiologist, 100%, 94% and 0.970 for subspecialized radiologist and 57.2%, 93.4%, and 0.927 using a MRI radiomics model obtained combining texture analysis on various MRI sequences. Sensitivity, specificity, and AUROC for the differential diagnosis between pleomorphic adenoma and Warthin tumors were 81.5%, 70%, and 0.757 for non-subspecialized radiologist, 81.5%, 95% and 0.882 for subspecialized radiologist and 70.8%, 82.5%, and 0.808 using a MRI radiomics model based on texture analysis of weighted sequence. A combined radiomics model obtained with all MRI sequences yielded a sensitivity of 91.5% for the diagnosis of pleomorphic adenoma.

Conclusion: MRI qualitative radiologist assessment outperforms radiomic analysis for the diagnosis of malignancy. MRI predictive radiomics models improves the diagnostic performance of non-subspecialized radiologist for the differential diagnosis between pleomorphic adenoma and Warthin tumor, achieving similar performance to the subspecialized radiologist.

Advances In Knowledge: Radiologists outperform radiomic analysis for the diagnosis of malignant parotid gland tumors, with some MRI qualitative features such as ill-defined margins, perineural spread, invasion of adjacent structures and enlarged lymph nodes being highly specific for malignancy. A radiomic model based on texture analysis of weighted images yields higher specificity for the diagnosis of pleomorphic adenoma compared to a radiologist non-subspecialized in head and neck radiology, thus minimizing false-positive pleomorphic adenoma diagnosis rate and reducing unnecessary surgical complications.

Citing Articles

Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations.

Basirinia G, Ali M, Comelli A, Sperandeo A, Piana S, Alongi P Cancers (Basel). 2024; 16(19).

PMID: 39409942 PMC: 11476023. DOI: 10.3390/cancers16193323.


Diagnostic performance of MRI-based radiomics models using machine learning approaches for the triple classification of parotid tumors.

Guo J, Feng J, Huang Y, Li X, Hu Z, Zhou Q Heliyon. 2024; 10(17):e36601.

PMID: 39263059 PMC: 11387325. DOI: 10.1016/j.heliyon.2024.e36601.


The value of T1- and FST2-Weighted-based radiomics nomogram in differentiating pleomorphic adenoma and Warthin tumor.

Sun H, Sun Z, Wang W, Cha X, Jiang Q, Wang X Transl Oncol. 2024; 49:102087.

PMID: 39159554 PMC: 11380391. DOI: 10.1016/j.tranon.2024.102087.


Different MRI-based radiomics models for differentiating misdiagnosed or ambiguous pleomorphic adenoma and Warthin tumor of the parotid gland: a multicenter study.

Yang J, Bi Q, Jin Y, Yang Y, Du J, Zhang H Front Oncol. 2024; 14:1392343.

PMID: 38939335 PMC: 11208325. DOI: 10.3389/fonc.2024.1392343.


Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma.

Wang M, Xi Y, Wang L, Chen H, Jiang F, Ding Z Radiat Oncol. 2024; 19(1):26.

PMID: 38418994 PMC: 10900635. DOI: 10.1186/s13014-024-02417-6.


References
1.
Mikaszewski B, Markiet K, Smugala A, Stodulski D, Szurowska E, Stankiewicz C . Diffusion-weighted MRI in the differential diagnosis of parotid malignancies and pleomorphic adenomas: can the accuracy of dynamic MRI be enhanced?. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; 124(1):95-103. DOI: 10.1016/j.oooo.2017.03.007. View

2.
Bjorndal K, Krogdahl A, Hamilton Therkildsen M, Overgaard J, Johansen J, Kristensen C . Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol. 2011; 47(7):677-82. DOI: 10.1016/j.oraloncology.2011.04.020. View

3.
Sumi M, Van Cauteren M, Sumi T, Obara M, Ichikawa Y, Nakamura T . Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology. 2012; 263(3):770-7. DOI: 10.1148/radiol.12111248. View

4.
Elmokadem A, Abdel Khalek A, Abdel Wahab R, Tharwat N, Gaballa G, Elata M . Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging for Differentiation Between Parotid Neoplasms. Can Assoc Radiol J. 2019; 70(3):264-272. DOI: 10.1016/j.carj.2018.10.010. View

5.
Kashiwagi N, Murakami T, Nakanishi K, Maenishi O, Okajima K, Takahashi H . Conventional MRI findings for predicting submandibular pleomorphic adenoma. Acta Radiol. 2013; 54(5):511-5. DOI: 10.1177/0284185113475922. View